These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28620983)

  • 1. Effects of glycolic acid peeling on the cutaneous manifestation of generalized acanthosis nigricans caused by FGFR3 mutation: A report of one sporadic and two familial cases.
    Ichiyama S; Kubo A; Matayoshi T; Saeki H; Funasaka Y
    J Dermatol; 2017 Oct; 44(10):e250-e251. PubMed ID: 28620983
    [No Abstract]   [Full Text] [Related]  

  • 2. Effective treatment by glycolic acid peeling for cutaneous manifestation of familial generalized acanthosis nigricans caused by FGFR3 mutation.
    Ichiyama S; Funasaka Y; Otsuka Y; Takayama R; Kawana S; Saeki H; Kubo A
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):442-5. PubMed ID: 26818779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial acanthosis nigricans with p.K650T FGFR3 mutation.
    Fukuchi K; Tatsuno K; Matsushita K; Kubo A; Ito T; Tokura Y
    J Dermatol; 2018 Feb; 45(2):207-210. PubMed ID: 29068064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial acanthosis nigricans with the FGFR3 mutation: Differences of pigmentation between male and female patients.
    Yasuda M; Morimoto N; Shimizu A; Toyoshima T; Yokoyama Y; Ishikawa O
    J Dermatol; 2018 Nov; 45(11):1357-1361. PubMed ID: 30168875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of efficacy and safety of tretinoin 0.05% and glycolic acid peeling 70% in axillary and neck lesions of acanthosis nigricans: A single-blinded, randomized trial.
    Ghiasi M; Samii R; Tootoonchi N; Balighi K; Heidari S
    J Cosmet Dermatol; 2024 Jun; 23(6):2090-2096. PubMed ID: 38362706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial acanthosis nigricans due to K650T FGFR3 mutation.
    Berk DR; Spector EB; Bayliss SJ
    Arch Dermatol; 2007 Sep; 143(9):1153-6. PubMed ID: 17875876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature.
    Blomberg M; Jeppesen EM; Skovby F; Benfeldt E
    Dermatology; 2010; 220(4):297-305. PubMed ID: 20453470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acanthosis nigricans in a Chinese girl with FGFR3 K650 T mutation: a case report and literature review.
    Fu J; Zhao Y; Wang T; Zhang Q; Xiao X
    BMC Med Genet; 2019 Jan; 20(1):8. PubMed ID: 30635042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mosaic mutations in FGFR3 and FGFR2 are associated with naevoid acanthosis nigricans or RAVEN (round and velvety epidermal naevus).
    Larsabal M; Cogrel O; Caumont C; Jegou MH; Taïeb A; Morice-Picard F
    Br J Dermatol; 2019 Jan; 180(1):201-202. PubMed ID: 30117157
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical sirolimus therapy for epidermal nevus with features of acanthosis nigricans.
    Dodds M; Maguiness S
    Pediatr Dermatol; 2019 Jul; 36(4):554-555. PubMed ID: 30983034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal dominant familial acanthosis nigricans caused by a C-terminal nonsense mutation of FGFR3.
    Tahara U; Yasuda M; Yamada Y; Aoki S; Sato S; Amagai M; Kubo A
    J Hum Genet; 2021 Aug; 66(8):831-834. PubMed ID: 33580140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous features of Crouzon syndrome with acanthosis nigricans.
    Mir A; Wu T; Orlow SJ
    JAMA Dermatol; 2013 Jun; 149(6):737-41. PubMed ID: 23571469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypochondroplasia and acanthosis nigricans with FGFR3 K650T mutation.
    Cossiez Cacard MA; Coulombe J; Bernard P; Kaci N; Bressieux JM; Souchon PF; Motte J; Legeai-Mallet L; Hadj-Rabia S; Eschard C
    J Eur Acad Dermatol Venereol; 2016 May; 30(5):897-8. PubMed ID: 25809207
    [No Abstract]   [Full Text] [Related]  

  • 14. Acanthosis nigricans and hypochondroplasia in a child with a K650Q mutation in FGFR3.
    Berk DR; Boente Mdel C; Montanari D; Toloza MG; Primc NB; Prado MI; Bayliss SJ; Pique LM; Schrijver I
    Pediatr Dermatol; 2010; 27(6):664-6. PubMed ID: 21510009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical therapy with tretinoin and ammonium lactate for acanthosis nigricans associated with obesity.
    Blobstein SH
    Cutis; 2003 Jan; 71(1):33-4. PubMed ID: 12553628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement of acanthosis nigricans on isotretinoin and metformin.
    Walling HW; Messingham M; Myers LM; Mason CL; Strauss JS
    J Drugs Dermatol; 2003 Dec; 2(6):677-81. PubMed ID: 14711151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nevoid acanthosis nigricans or RAVEN (rounded and velvety epidermal nevus): three cases].
    Petit A; Lemarchand-Venencie F; Pinquier L; Lebbe C; Bourrat E
    Ann Dermatol Venereol; 2012 Mar; 139(3):183-8. PubMed ID: 22401682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acanthosis nigricans in a child with mild osteochondrodysplasia and K650Q mutation in the FGFR3 gene.
    Leroy JG; Nuytinck L; Lambert J; Naeyaert JM; Mortier GR
    Am J Med Genet A; 2007 Dec; 143A(24):3144-9. PubMed ID: 18000903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crouzon syndrome with acanthosis nigricans: a case-based update.
    Di Rocco F; Collet C; Legeai-Mallet L; Arnaud E; Le Merrer M; Hadj-Rabia S; Renier D
    Childs Nerv Syst; 2011 Mar; 27(3):349-54. PubMed ID: 21136065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypochondroplasia and Acanthosis nigricans: a new syndrome due to the p.Lys650Thr mutation in the fibroblast growth factor receptor 3 gene?
    Castro-Feijóo L; Loidi L; Vidal A; Parajes S; Rosón E; Alvarez A; Cabanas P; Barreiro J; Alonso A; Domínguez F; Pombo M
    Eur J Endocrinol; 2008 Sep; 159(3):243-9. PubMed ID: 18583390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.